Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Related Articles by Review for PubMed (Select 22903071)

1.
2.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
3.

Olanzapine: an updated review of its use in the management of schizophrenia.

Bhana N, Foster RH, Olney R, Plosker GL.

Drugs. 2001;61(1):111-61. Review.

PMID:
11217867
4.

Conditioned avoidance response in the development of new antipsychotics.

Wadenberg ML.

Curr Pharm Des. 2010 Jan;16(3):358-70. Review.

PMID:
20109144
6.

Behavioral pharmacology of olanzapine: a novel antipsychotic drug.

Moore NA, Leander JD, Benvenga MJ, Gleason SD, Shannon H.

J Clin Psychiatry. 1997;58 Suppl 10:37-44. Review.

PMID:
9265915
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk